STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
<p>One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.</p>